# Endurant Stent Graft System Post Approval Study (ENGAGE PAS)

Study · id `cardio:ct-nct01379222` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01379222](<https://clinicaltrials.gov/study/NCT01379222>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT01379222

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

## Technical summary

Registry record NCT01379222. Allocation not applicable; no masking; primary purpose treatment. Start 2011-08 (registry gives no type); primary completion 2017-12 (actual). Results posted on 2019-02-04.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 178 participants (enrolled count; ClinicalTrials.gov record NCT01379222, source copy `cardio:ctgov-nct01379222-2021-10-29`, retrieved 2026-11-18)
- Start date: 2011-08 (registry gives no type) (ClinicalTrials.gov record NCT01379222, source copy `cardio:ctgov-nct01379222-2021-10-29`, retrieved 2026-11-18)
- Primary completion: 2017-12 (actual) (ClinicalTrials.gov record NCT01379222, source copy `cardio:ctgov-nct01379222-2021-10-29`, retrieved 2026-11-18)
- Completion: 2017-12 (actual) (ClinicalTrials.gov record NCT01379222, source copy `cardio:ctgov-nct01379222-2021-10-29`, retrieved 2026-11-18)
- Results first posted: 2019-02-04 (ClinicalTrials.gov record NCT01379222, source copy `cardio:ctgov-nct01379222-2021-10-29`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT01379222, source copy `cardio:ctgov-nct01379222-2021-10-29`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01379222-2021-10-29`, retrieved 2026-11-18)

## The registry's words

- Brief title: Endurant Stent Graft System Post Approval Study (ENGAGE PAS)
- Condition: Aortic Aneurysm, Abdominal
- Intervention (Device): Endurant Stent Graft System
- Lead sponsor: Medtronic Cardiovascular
- Lead sponsor class: INDUSTRY
- Collaborator: Duke Clinical Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Abdominal aortic aneurysm (`cardio:abdominal-aortic-aneurysm`)
- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Medtronic (`cardio:medtronic`)
- Registry lists this organization as a collaborator: Duke Clinical Research Institute (`cardio:org-duke-clinical-research-institute`)

## Provenance

Content hash: 3c9d085cb795d81534f0568f36944ba6e8f08066965d60511a7e0cca54bb0e25
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
